Trial Profile
Investigating the effect of maraviroc on Microbial Translocation in HIV infected individuals who are receiving antiretroviral therapy: a phase IV, prospective, intervention study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- Acronyms MT-Study
- 02 Apr 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
- 19 Dec 2013 Accrual to date is 50% according to United Kingdom Clinical Research Network record.
- 04 Dec 2013 Accrual to date is 40% according to United Kingdom Clinical Research Network record.